17 Canadian venture capital firms investing in HealthTech / Life Sciences at Series B+ stage. Browse their thesis focus, check sizes, and recent deals below.
Canada's Global Life Sciences Venture, sourcing promising therapeutics research from academic and biotech partners to create new companies of scale and train the next generation of life sciences leade
The $300M direct investment component of BDC's Thrive Platform, addressing the equity gap faced by women-led companies. Partners with women entrepreneurs building Canadian technology companies.
A $200M fund — one of the world's largest dedicated to investing in women-led tech companies. Made 38 investments with 8 successful exits. Predecessor to the Thrive Platform.
Early-stage venture capital firm focused on Atlantic Canada, investing from seed through Series C.
Venture capital fund investing in innovative Canadian companies in the food & beverage and health & wellness sectors.
Award-winning commercialization venture firm building companies with entrepreneurs to accelerate oncology innovation, partnered with the Ontario Institute for Cancer Research (OICR).
Toronto-based growth capital firm founded in 2008, one of Canada's largest investment firms, investing in enterprise software and internet companies with nearly $3B raised across 5 growth funds.
Leading seed-stage venture capital fund based in Toronto, investing across North America with 7 funds raised and 140 deals recorded.
Growth capital investment firm providing private funding and merchant banking services to a wide variety of businesses at different stages of development.
Fund igniting precision medicine by supporting early-stage discoveries; innovation arm at the intersection of AI and biomarker analysis for metabolic diseases including cancer and diabetes.
Bridges a critical gap in early-stage funding, catalyzing later-stage funding for promising technology companies across enterprise software, health tech, clean tech and deep tech.
Global venture capital company focused on equity financing of innovative biotechnology companies with breakthrough technology platforms.
Backer of Canada's most daring innovators and idea generators; RBC's technology growth banking and venture arm.
Private venture capital and mutual fund management company with 1 fund and 51 deals recorded.
Emerging life science companies developing innovative medical treatments based on disruptive technologies.
Building global healthcare leaders from locally disruptive technologies. MedTech, Biotech, AI in Health.
International technology investment manager. Early Growth Fund, Digital Asset Fund, and North American Seed Fund.